Myeloma Therapy
Data on myeloma therapy published by researchers at University of California
Published in Gene Therapy Weekly, May 28th, 2009
Data detailed in 'A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells' have been presented. According to recent research published in the journal Human Molecular Genetics, "Ectopic activation of fibroblast growth factor receptor 3 (FGFR3) is associated with several cancers, including multiple myeloma (MM). FGFR3 inhibition in these cells inhibits proliferation and induces apoptosis, validating FGFR3 signaling as a therapeutic target in t(4;14) MM cases."
"We have identified the PI3K regulatory subunit, p85alpha, as a novel...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-05-28)
More Articles from Gene Therapy Weekly
- Breast Cancer
Reports from G.Q. Hua et al highlight recent research in breast cancer - Breast Cancer
Reports on breast cancer findings from Baylor College of Medicine, College of Medicine provide new insights - Breast Cancer
Research from University of London, Imperial College reveals new findings on breast cancer - Breast Cancer
Studies from Northwestern University update current data on breast cancer - Cancer
Findings from University of Texas provide new insights into cancer - Cancer Gene Therapy
Data on cancer gene therapy published by J.A. Westwood and colleagues - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
